Submit an abstract

We welcome the submission of abstracts for presentation at the fifth conference on 27 May 2021 on the theme Making the invisible visible: understanding the hidden symptoms of MS.

Original abstracts (but not encores) will be considered for publication in Multiple Sclerosis and Related Disorders.

Important dates

Abstract submission opens                                     Thursday 4 February 2021

Abstract submission deadline                                 Friday 5 March 2021 at 22:00 GMT

Notification of abstract acceptance                      Friday 19 March 2021

Poster and audio commentary deadline               Friday 30 April 2021


Once an abstract has been accepted we will contact you to develop a poster. We encourage authors to provide an audio commentary alongside your poster so that you can explain your research in further detail.

To submit your abstract:

  • Download the abstract submission form and abstract guidance documents from the links below
  • Once the abstract submission form is complete, please email us directly at

For further details on topics please see the section below.

Topics for abstract submission

Abstracts on the topics below will be considered for acceptance. When you submit your form, please select the most appropriate topic.

  • Vaccination in MS
  • Management of MS during the COVID-19 pandemic
  • 'Hidden' symptoms in MS: impact and therapeutic approaches
  • Digital health and telemedicine in MS
  • Advances in therapy in MS
  • Progressive MS: updates on pathology, inflammation or therapy


There is no limit to the numbr of authors per abstract.

Please note, no corrections or alterations can be made after the abstract and poster deadlines.

Authors will be notified by email by Friday 19 March 2021 whether their abstract has been accepted. The team will then contact you to request your poster and the audio recording of your poster commentary.

The corresponding author is responsible for informing the co-authors about the status of the abstract/poster. Please ensure that the corresponding author’s email address, as well as full name, are correct.


If you have any questions, please contact the team at